Esperante Development

Esperante is a privately held life science investment company that serves as the investment arm of the C&P Group. Based in the Netherlands with a presence in the United Kingdom, the firm specializes in providing capital and strategic support to clinical-stage biotechnology companies. The firm's investment focus primarily targets therapeutics for oncology, rare diseases, immunology, and other areas of significant unmet medical need. Esperante typically invests in companies with assets in Phase I through Phase III development, aiming to facilitate the transition from clinical research to commercial success. In addition to financial backing, the firm provides strategic guidance and leverages its extensive industry network to support its portfolio companies. Esperante maintains a global investment mandate and frequently collaborates with other leading venture capital firms in the life sciences sector.